Skip to main content
Premium Trial:

Request an Annual Quote

SpeeDx, LabCorp Will Codevelop MDx Tests

NEW YORK – SpeeDx said on Monday it has agreed with Laboratory Corporation of America to codevelop diagnostic tests. The agreement focuses on assays for women's health and infectious diseases.

SpeeDx and LabCorp will work together to codevelop and introduce new molecular tests using SpeeDx's proprietary technology, the Australia-based firm said in an email. Financial terms were not disclosed.

"SpeeDx and LabCorp have a mutual goal to bring enhanced testing solutions to US patients," said Colin Denver, SpeeDx's CEO. "We are excited about the impact this collaboration can have as we support LabCorp and their ongoing commitment to bring high-quality, high-value testing services to clinicians and patients across the US," Denver added.

SpeeDx has submitted its test for molecular detection of Mycoplasma genitalium and resistance genes to the US Food and Drug Administration and anticipates approval this quarter. The firm also recently announced a collaboration with QuantuMDx and FIND to develop point-of-care testing sexually transmitted infection testing. Its M. gen test on the Cepheid FleXible cartridge system received CE mark in September and its test for gonorrhea and drug resistance is also CE marked.

The Scan

University of Michigan President Fired

Mark Schlissel, the president of the University of Michigan, has been fired after an investigation into allegations he had an affair with a subordinate, the Washington Post reports.

Recommendation to Drop Charges

The Wall Street Journal says federal prosecutors recommended charges against MIT's Gang Chen, who was caught up by the China Initiative, be dropped.

Mix 'Em Together

The Guardian reports Moderna is planning to have a combination SARS-CoV-2, influenza, and RSV vaccine by the 2023 flu season.

PNAS Papers on Earth BioGenome Project, SETX Knockouts, Pig Model of Cystic Fibrosis

In PNAS this week: Earth BioGenome Project reports progress, analysis of cells missing the progressive neurodegenerative disease-linked SETX gene, and more.